Return to Arthritis & Rheumatism Table of Contents Page
| Special Articles |
|
|---|---|
| 3115 |
Editorial: Missed Opportunities in Physician Management of Glucocorticoid-Induced Osteoporosis? |
| Rosalind Ramsey-Goldman |
|
| 3121 |
Review: Osteoprotegerin, an Endogenous Antiosteoclast Factor for Protecting Bone in Rheumatoid Arthritis |
| Brad Bolon, Victoria Shalhoub, Paul J. Kostenuik, Giuseppe Campagnuolo, Sean Morony, William J. Boyle, Debra Zack, and Ulrich Feige |
|
| Rheumatoid Arthritis |
|
| 3136 |
Management of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatoid Arthritis: Rates and Predictors of Care in an Academic Rheumatology Practice |
| Daniel H. Solomon, Jeffrey N. Katz, Jonathan P. Jacobs, Alison M. La Tourette, and Jonathan Coblyn |
|
| 3143 |
Therapeutic Benefit of Blocking Interleukin-6 Activity With an Anti-Interleukin-6 Receptor Monoclonal Antibody in Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial |
| E. H. S. Choy, D. A. Isenberg, T. Garrood, S. Farrow, Y. Ioannou, H. Bird, N. Cheung, B. Williams, B. Hazleman, R. Price, K. Yoshizaki, N. Nishimoto, T. Kishimoto, and G. S. Panayi |
|
| 3151 |
Tumor Necrosis Factor Antagonist Therapy and Lymphoma Development: Twenty-Six Cases Reported to the Food and Drug Administration |
| S. Lori Brown, Mark H. Greene, Sharon K. Gershon, Evelyne T. Edwards, and M. Miles Braun |
|
| 3159 |
Induction of Apoptosis in Rheumatoid Synovial Fibroblasts by Celecoxib, but Not by Other Selective Cyclooxygenase 2 Inhibitors |
| Natsuko Kusunoki, Ryuta Yamazaki, and Shinichi Kawai |
|
| 3168 |
The Geometric Architecture of the Subtalar and Midtarsal Joints in Rheumatoid Arthritis Based on Magnetic Resonance Imaging |
| James Woodburn, Jayaram K. Udupa, Bruce E. Hirsch, Richard J. Wakefield, Philip S. Helliwell, Naomi Reay, Philip O'Connor, Adam Budgen, and Paul Emery |
|
| Osteoarthritis and Cartilage |
|
| 3178 |
Evidence for Increased Bone Resorption in Patients With Progressive Knee Osteoarthritis: Longitudinal Results From the Chingford Study |
| Paolo Bettica, Gary Cline, Deborah J. Hart, Joan Meyer, and Tim D. Spector |
|
| 3185 |
Nonrandom Evolution of End-Stage Osteoarthritis of the Lower Limbs |
| Najia Shakoor, Joel A. Block, Susan Shott, and John P. Case |
|
| 3190 |
Functional Replacement of Oxygen by Other Oxidants in Articular Cartilage |
| Robert B. Lee and Jill P. G. Urban |
|
| 3201 |
Growth-Related Oncogene [alpha] Induction of Apoptosis in Osteoarthritis Chondrocytes |
| Rosa Maria Borzi, Ilaria Mazzetti, Giorgia Magagnoli, Samantha Paoletti, Mariagrazia Uguccioni, Rita Gatti, Guido Orlandini, Luca Cattini, and Andrea Facchini |
|
| 3212 |
Induction of Advanced Glycation End Products and Alterations of the Tensile Properties of Articular Cartilage |
| Albert C. Chen, Michele M. Temple, Darren M. Ng, Nicole Verzijl, Jeroen DeGroot, Johan M. TeKoppele, and Robert L. Sah |
|
| 3218 |
Up-Regulated Expression of Cartilage Intermediate-Layer Protein and ANK in Articular Hyaline Cartilage From Patients With Calcium Pyrophosphate Dihydrate Crystal Deposition Disease |
| Jun Hirose, Lawrence M. Ryan, and Ikuko Masuda |
|
| 3230 |
Bcl-3 Is an Interleukin-1-Responsive Gene in Chondrocytes and Synovial Fibroblasts That Activates Transcription of the Matrix Metalloproteinase 1 Gene |
| Sarah F. Elliott, Charles I. Coon, Ezra Hays, Terrance A. Stadheim, and Matthew P. Vincenti |
|
| 3240 |
Expression of Matrix Metalloproteinases in Articular Cartilage of Temporomandibular and Knee Joints of Mice During Growth, Maturation, and Aging |
| Amira Gepstein, Sarah Shapiro, Gil Arbel, Nitza Lahat, and Erella Livne |
|
| Systemic Lupus Erythematosus and Autoimmunity |
|
| 3251 |
Treatment of Systemic Lupus Erythematosus by Inhibition of T Cell Costimulation With Anti-CD154: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Kenneth C. Kalunian, John C. Davis, Jr., Joan T. Merrill, Mark C. Totoritis, and David Wofsy, for the IDEC-131 Lupus Study Group |
|
| 3259 |
RP105-Lacking B Cells From Lupus Patients Are Responsible for the Production of Immunoglobulins and Autoantibodies |
| Yuji Kikuchi, Syuichi Koarada, Yoshifumi Tada, Osamu Ushiyama, Fumitaka Morito, Noriaki Suzuki, Akihide Ohta, Kensuke Miyake, Masao Kimoto, Takahiko Horiuchi, and Kohei Nagasawa |
|
| 3266 |
Identity of the RNase MRP- and RNase P-Associated Th/To Autoantigen |
| Hans van Eenennaam, Judith H. P. Vogelzangs, Dorien Lugtenberg, Frank H. J. van den Hoogen, Walther J. van Venrooij, and Ger J. M. Pruijn |
|
| 3273 |
A New Conformational Epitope Generated by the Binding of Recombinant 70-kd Protein and U1 RNA to Anti-U1 RNP Autoantibodies in Sera From Patients With Mixed Connective Tissue Disease |
| Akihiro Murakami, Kazuo Kojima, Kazuhiko Ohya, Koji Imamura, and Yoshinari Takasaki |
|
| 3283 |
Effects of [beta]2-Glycoprotein I and Monoclonal Anticardiolipin Antibodies in Platelet Interaction With Subendothelium Under Flow Conditions |
| Josep Font, Gerard Espinosa, Dolors Tassies, Marc Pino, Munther A. Khamashta, Teresa Gallart, Ricard Cervera, Gines Escolar, Graham R. V. Hughes, Miguel Ingelmo, Antoni Ordinas, and Joan-Carles Reverter |
|
| 3290 |
Induction of Cell Death by Sera From Patients With Acute Brain Injury as a Mechanism of Production of Autoantibodies |
| Herminio Lopez-Escribano, Eduardo Minambres, Moises Labrador, Maria Jose Bartolome, and Marcos Lopez-Hoyos |
|
| Sjogren's Syndrome |
|
| 3301 |
Infliximab in Primary Sjogren's Syndrome: One-Year Followup |
| Serge D. Steinfeld, Paul Demols, and Thierry Appelboom |
|
| Childhood Arthritis |
|
| 3304 |
Linkage and Association Studies of Single-Nucleotide Polymorphism-Tagged Tumor Necrosis Factor Haplotypes in Juvenile Oligoarthritis |
| Eleftheria Zeggini, Wendy Thomson, Dominic Kwiatkowski, Anna Richardson, William Ollier, Rachelle Donn, and The British Paediatric Rheumatology Study Group |
|
| Systemic Sclerosis |
|
| 3312 |
Cigarette Smoking as a Significant Risk Factor for Digital Vascular Disease in Patients With Systemic Sclerosis |
| Beverley J. Harrison, Alan J. Silman, Samantha L. Hider, and Ariane L. Herrick |
|
| Vasculitis |
|
| 3317 |
Interferon-[alpha] and Ribavirin Treatment in Patients With Hepatitis C Virus-Related Systemic Vasculitis |
| Patrice Cacoub, Olivier Lidove, Thierry Maisonobe, Pierre Duhaut, Vincent Thibault, Pascale Ghillani, Robert P. Myers, Jean Marc Leger, Jerome Servan, and Jean-Charles Piette |
|
| Surgical Treatment |
|
| 3327 |
Timing of Total Joint Replacement Affects Clinical Outcomes Among Patients With Osteoarthritis of the Hip or Knee |
| Paul R. Fortin, John R. Penrod, Ann E. Clarke, Yvan St-Pierre, Lawrence Joseph, Patrick Belisle, Matthew H. Liang, Diane Ferland, Charlotte B. Phillips, Nizar Mahomed, Michael Tanzer, Clement Sledge, Anne H. Fossel, and Jeffrey N. Katz |
|
| 3331 |
The Effect of Education and Income on Need and Willingness to Undergo Total Joint Arthroplasty |
| Gillian A. Hawker, James G. Wright, Richard H. Glazier, Peter C. Coyte, Bart Harvey, J. Ivan Williams, and Elizabeth M. Badley |
|
| Genetics |
|
| 3340 |
De Novo CIAS1 Mutations, Cytokine Activation, and Evidence for Genetic Heterogeneity in Patients With Neonatal-Onset Multisystem Inflammatory Disease (NOMID): A New Member of the Expanding Family of Pyrin-Associated Autoinflammatory Diseases |
| Ivona Aksentijevich, Miroslawa Nowak, Mustapha Mallah, Jae Jin Chae, Wendy T. Watford, Sigrun R. Hofmann, Leonard Stein, Ricardo Russo, Donald Goldsmith, Peter Dent, Helene F. Rosenberg, Frances Austin, Elaine F. Remmers, James E. Balow, Jr., Sergio Rosenzweig, Hirsh Komarow, Nitza G. Shoham, Geryl Wood, Janet Jones, Nadira Mangra, Hector Carrero, Barbara S. Adams, Terry L. Moore, Kenneth Schikler, Hal Hoffman, Daniel J. Lovell, Robert Lipnick, Karyl Barron, John J. O'Shea, Daniel L. Kastner, and Raphaela Goldbach-Mansky |
|
| Pathogenesis and Biology |
|
| 3349 |
Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells |
| Elena A. Jones, Sally E. Kinsey, Anne English, Richard A. Jones, Liz Straszynski, David M. Meredith, Alex F. Markham, Andrew Jack, Paul Emery, and Dennis McGonagle |
|
| Animal Models |
|
| 3361 |
Inhibition of Adjuvant-Induced Arthritis by Systemic Tissue Inhibitor of Metalloproteinases 4 Gene Delivery |
| Mahmut Y. Celiker, Nungavaram Ramamurthy, Jin-Wen Xu, Mingsheng Wang, Yangfu Jiang, Robert Greenwald, and Y. Eric Shi |
|
| 3369 |
Peptide-Induced Suppression of Collagen-Induced Arthritis in HLA-DR1 Transgenic Mice |
| Linda K. Myers, Yoshihiko Sakurai, B. Tang, Xiaowen He, Edward F. Rosloniec, John M. Stuart, and Andrew H. Kang |
|
| 3378 |
Relief of Inflammatory Pain in Rats by Local Use of the Selective P2X7 ATP Receptor Inhibitor, Oxidized ATP |
| Giacomo Dell'Antonio, Angelo Quattrini, Elena Dal Cin, Alessandro Fulgenzi, and Maria Elena Ferrero |
|
| Concise Communications |
|
| 3386 |
Investigation of Linkage on Chromosome 2q and Hand and Knee Osteoarthritis |
| Emma Gillaspy, Kristian Spreckley, Gillian Wallis, Michael Doherty, and Tim D. Spector |
|
| 3388 |
Humanized Monoclonal Anti-Interleukin-6 Receptor Antibody for Treatment of Intractable Adult-Onset Still's Disease |
| Masahiro Iwamoto, Hiroyuki Nara, Daisuke Hirata, Seiji Minota, Norihiro Nishimoto, and Kazuyuki Yoshizaki |
|
| Letters |
|
| 3390 |
The Value of Rheumatologists to Patients With Fibromyalgia: Comment on the Presidential Address by Weinblatt |
| Andrew J. Holman |
|
| 3390 |
Reply |
| Michael E. Weinblatt |
|
| 3390 |
Increased Osteoprotegerin and Decreased Pyridinoline Levels in Patients With Ankylosing Spondylitis: Comment on the Article by Gratacos et al |
| Ricardo Prado Golmia, Branca Dias Batista Sousa, and Morton Aaron Scheinberg |
|
| 3392 |
Reply |
| Jordi Gratacos and Raimon Sanmarti |
|
| 3392 |
Increased Cutaneous Reactions to Hydroxychloroquine (Plaquenil) Possibly Associated With Formulation Change: Comment on the Letter by Alarcon |
| M. Salido, B. Joven, D. P. D'Cruz, M. A. Khamashta, and G. R. V. Hughes |
|
| 3396 |
Efficacy of Tumor Necrosis Factor [alpha] Blockade for Enthesitis in Spondylarthropathy: Comment on the Article by Marzo-Ortega et al |
| Ignazio Olivieri, Angela Padula, and Enrico Scarano |
|
| 3398 |
Reply |
| Helena Marzo-Ortega, Dennis McGonagle, and Paul Emery |
|
| 3398 |
Erratum |
| 3398 |
Author's Name Omitted From Article by Aganna et al (Arthritis Rheum, September 2002) |
| 3399 |
Second-Year Fellow Abstracts and Late Breaking Abstracts, American College of Rheumatology 2002 Annual Scientific Meeting |
| 3422 |
Reviewers |
| 3427 |
Contents, Volume 46, 2002 |
| 3461 |
Indexes |
|
Cover image: The figure on the cover (from Kusunoki et al, page 3164) demonstrates the occurrence of apoptosis in rheumatoid synovial fibroblasts treated with celecoxib. The brown cells are apoptotic as shown by TUNEL staining. This finding suggests an action of celecoxib that is not dependent on cyclooxygenase 2 inhibition and may be relevant to the activity of this drug in the treatment of rheumatoid arthritis. |
|




